Rumors are spreading that Hanmi Pharm did buy up a 1-percent stake in Dong-A Pharm at the end of last year to support Dong-A's chairman Kang Shin-ho.
Hanmi denied such allegations flatly, saying its buying is closely associated with Dong-A's potential growth by Zydena's launching.
However, Analysts said Kang is at feud with his second son Kang Moon-seok, the chief executive of Sooseok Tra...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.